Compare Denver Biomedical vs Micronics Microfluidics
Customers evaluate the quality of Denver Biomedical's products using the following success metrics.
Overview
Denver Biomedical is 55 yrs old and is based in United States.
Denver Biomedical, Inc., a manufacturer, distributor and marketer of disposable medical devices for the outpatient management of recurrent malignant pleural effusions (MPE), was acquired by Cardinal Health, Inc. (NYSE: CAH) in May 2006.
Micronics Microfluidics is 28 yrs old and is based in United States.
Micronics is advancing a portfolio of point of care products for disease detection, diagnosis and treatment monitoring. The company employs an estate in microfluidics and related technologies that make it possible to process biological and environmental samples directly in disposable devices and to perform highly accurate and affordable tests in a fraction of the time required by most molecular diagnostic tests in use today. Micronics is involved in the research and development of near patient Point of Care devices for disease diagnosis, treatment monitoring and blood testing, and also provides product development for third-party clients. In September 2011, Micronics was acquired by Sony Corp's US subsidiary, Sony Corporation of America. Micronics' valuation was not disclosed nor were other terms of the transaction.
Demo Video
Investors
Cardinal Health and CID Capital
Sony, National Institutes of Health
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Denver Biomedical has not claimed their profile.
Work for Denver Biomedical? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Denver Biomedical?
Claim your profile now.
Information not available because Micronics Microfluidics has not claimed their profile.
Work for Micronics Microfluidics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Micronics Microfluidics?
Claim your profile now.